Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAP DM1: Amlodipine in Myotonic Dystrophy Type 1
NCT07075965Phase 1Not yet recruiting
- Sponsor
- University of Rochester
- Start
- Dec 2026
- Primary completion
- Oct 2030
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of amlodipine in myotonic dystrophy type 1 (DM1) (2 cohorts), sponsored by University of Rochester. Primary endpoints: Number of Subjects Who Provided Informed Consent, Number of Completed Study Visits and 2 more. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
amlodipine
03
Conditions
myotonic dystrophy type 1 (DM1)
Beyond the preview
Go deeper on NCT07075965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07075965.